S. David Ellenbogen, Hologic’s chair and CEO, died unexpectedly June 21 from heart failure. A pioneer of bone densitometry, Ellenbogen cofounded Hologic and served as CEO and chair since its formation 16 years ago. In addition to corporate duties
S. David Ellenbogen, Hologic’s chair and CEO, died unexpectedly June 21 from heart failure. A pioneer of bone densitometry, Ellenbogen cofounded Hologic and served as CEO and chair since its formation 16 years ago. In addition to corporate duties at Hologic, Ellenbogen lobbied state and federal officials on behalf of small companies throughout the medical device industry. His professional efforts underscored the integrity and good will that friends and associates experienced firsthand. Jay A. Stein, executive vice president and CTO, has been appointed Hologic chair. Stein will serve as interim CEO, until the company’s board of directors fills the position permanently.
Can Generative AI Facilitate Simulated Contrast Enhancement for Prostate MRI?
January 14th 2025Deep learning synthesis of contrast-enhanced MRI from non-contrast prostate MRI sequences provided an average multiscale structural similarity index of 70 percent with actual contrast-enhanced prostate MRI in external validation testing from newly published research.
Can MRI Have an Impact with Fertility-Sparing Treatments for Endometrial and Cervical Cancers?
January 9th 2025In a literature review that includes insights from recently issued guidelines from multiple European medical societies, researchers discuss the role of magnetic resonance imaging (MRI) in facilitating appropriate patient selection for fertility-sparing treatments to address early-stage endometrial and cervical cancer.